Regeneron Pharma (REGN) PT Lowered to $1,130 at UBS
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $852.03 +3.42%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Join SI Premium – FREE
UBS analyst Colin Bristow lowered the price target on Regeneron Pharma (NASDAQ: REGN) to $1,130.00 (from $1,251.00) while maintaining a Buy rating.
You May Also Be Interested In
- Sprinklr Inc (CXM) PT Raised to $7.50 at Cantor Fitzgerald
- Dell (DELL) PT Raised to $505 at Truist Securities
- Comstock Resources (CRK) PT Raised to $17 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
